This register-based study on LRTIs shows that the use of CRP testing increased from 53.4% to 65.7% in the assessment of patients with acute bronchitis and from 61.3% to 77.5% for patients with pneumonia from January 2006 to December 2014. This evidence concerns the gene CRP and pneumonia.